Cutaneous Manifestations of COVID-19 in Children

Authors

  • Farhana Muzaffar Department of Pediatric Dermatology, Institute of Child Health/ The Children’s Hospital, Lahore.

Abstract

The severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) and the ensuant disease coronavirus disease 2019 (COVID‐19), has erupted as global pandemic. Clinical presentation, course and outcome of disease is different in children. Besides, respiratory symptoms, patients of COVID-19 can present with diverse cutaneous manifestations seen in 0.2% to 20% of patients, and 3.4% of children. Common dermatologic findings include pseudochilblain (COVID toes, maculopapular (morbilliform) exanthem, urticaria, vesicular rash, erythema multiforme and Kawasaki disease-like inflammatory multisystemic syndrome. Cutaneous involvement usually occurs concurrently with the systemic symptoms; nonetheless, these can follow or precede the systemic features. Any correlation between COVID-19 severity and cutaneous manifestations remains speculative. These cutaneous changes may guide to early diagnosis and treatment of COVID-19.

Author Biography

Farhana Muzaffar, Department of Pediatric Dermatology, Institute of Child Health/ The Children’s Hospital, Lahore.

Professor of Pediatric Dermatology

Downloads

Published

2021-03-04

Issue

Section

Review Articles